| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/01.AOG.0000154885.44002.AE |
| P698 | PubMed publication ID | 15738026 |
| P50 | author | Karen H. Lu | Q117217757 |
| Molly S. Daniels | Q37836881 | ||
| David Gershenson | Q57167281 | ||
| P2093 | author name string | Jane Green | |
| Thomas Burke | |||
| Sapna Syngal | |||
| Russell R Broaddus | |||
| Wendy Kohlmann | |||
| Patrick Lynch | |||
| Henry Lynch | |||
| Lee-May Chen | |||
| Jonathan Terdiman | |||
| Peggy Conrad | |||
| Brian Allen | |||
| Patrice Watson | |||
| Charlotte Sun | |||
| Prathap Bandipalliam | |||
| Mai Dinh | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal carcinoma | Q25493920 |
| Lynch syndrome | Q783644 | ||
| colorectal cancer | Q188874 | ||
| P304 | page(s) | 569-574 | |
| P577 | publication date | 2005-03-01 | |
| P1433 | published in | Obstetrics and Gynecology | Q7075543 |
| P1476 | title | Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. | |
| P478 | volume | 105 |
| Q64100755 | A Micro-Costing Study of Screening for Lynch Syndrome-Associated Pathogenic Variants in an Unselected Endometrial Cancer Population: Cheap as NGS Chips? |
| Q61796241 | A case of ovarian endometrioid adenocarcinoma with yolk sac differentiation and Lynch syndrome |
| Q35863143 | A clinically applicable molecular-based classification for endometrial cancers |
| Q35781136 | A national initiative for women and healthcare providers: CDC's Inside Knowledge: Get the Facts About Gynecologic Cancer campaign |
| Q37866075 | A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal carcinomas, skin sebaceous tumors, and gynecologic tract carcinomas |
| Q84316559 | Are prediction models for Lynch syndrome valid for probands with endometrial cancer? |
| Q51775699 | Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk. |
| Q46764474 | Awareness of gynecologic surveillance in women from hereditary non-polyposis colorectal cancer families |
| Q54503214 | Can reduced field-of-view diffusion sequence help assess microsatellite instability in FIGO stage 1 endometrial cancer? |
| Q35609272 | Clear cell cancer of the uterine corpus: the association of clinicopathologic parameters and treatment on disease progression |
| Q47895230 | Clinical characteristics of Lynch-like cases collaterally classified by Lynch syndrome identification strategy using universal screening in endometrial cancer. |
| Q38139284 | Clinical significance of microsatellite instability in colorectal cancer |
| Q46524243 | Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and younger |
| Q89723158 | Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinoma |
| Q44950903 | Colon cancer screening in women |
| Q37850387 | Colorectal cancer screening in women with endometrial cancer: are we following the guidelines? |
| Q30361978 | Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study |
| Q51552333 | Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries. |
| Q94587266 | Comparison of two Lynch screening strategies in endometrial cancer in a California health system |
| Q34017044 | Consequences of universal MSI/IHC in screening ENDOMETRIAL cancer patients for Lynch syndrome |
| Q83131182 | Consideration of hereditary nonpolyposis colorectal cancer in BRCA mutation-negative familial ovarian cancers |
| Q35837883 | Controversies in the management of endometrial carcinoma: an update |
| Q48952576 | Cost-effectiveness of routine screening for Lynch syndrome in endometrial cancer patients up to 70years of age. |
| Q57907570 | Counseling and Testing for Inherited Predisposition to Cancer |
| Q33738168 | Current and emerging trends in Lynch syndrome identification in women with endometrial cancer. |
| Q64883297 | Decreasing Trends of Secondary Primary Colorectal Cancer among Women with Uterine Cancer: A Population-Based Analysis. |
| Q36059087 | Do hereditary syndrome-related gynecologic cancers have any specific features? |
| Q36178261 | Endometrial and ovarian cancer in lynch syndrome |
| Q63199203 | Endometrial cancer |
| Q83269608 | Endometrial cancer |
| Q28303873 | Endometrial cancer and Lynch syndrome: clinical and pathologic considerations |
| Q33737568 | Endometrial cancer and a family history of cancer. |
| Q51526342 | Endometrial cancer patients and compliance with genetic counseling: room for improvement. |
| Q38852405 | Endometrial cancer: Not your grandmother's cancer |
| Q33874719 | Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer |
| Q34166420 | FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. |
| Q33646157 | Familial cancer among consecutive uterine cancer patients in Sweden |
| Q34265940 | Features of ovarian cancer in Lynch syndrome (Review). |
| Q37468316 | Genetic risk and gynecologic cancers. |
| Q36619933 | Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond |
| Q31139897 | Genetic testing strategies in newly diagnosed endometrial cancer patients aimed at reducing morbidity or mortality from lynch syndrome in the index case or her relatives |
| Q38212634 | Genetics of endometrial cancer |
| Q46508620 | Gynecologic cancer mortality in Trinidad and Tobago and comparisons of mortality-to-incidence rate ratios across global regions |
| Q37192947 | Gynecologic cancers associated with Lynch syndrome/HNPCC. |
| Q28085485 | Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment? |
| Q38241489 | Hereditary cancer syndromes with high risk of endometrial and ovarian cancer: surgical options for personalized care |
| Q38224227 | Hereditary colorectal cancer syndromes and genetic testing |
| Q34713100 | Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. |
| Q38067433 | Hereditary gynaecological malignancies: advances in screening and treatment |
| Q35235483 | Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing |
| Q51048185 | Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center. |
| Q47935364 | Importance of PCR-based Tumor Testing in the Evaluation of Lynch Syndrome-associated Endometrial Cancer |
| Q26801354 | Improving survival after endometrial cancer: the big picture |
| Q35626007 | Increased risk of second primary malignancies following uterine cancer: a population-based study in Taiwan over a 30-year period |
| Q59281170 | Knowledge of Lynch syndrome among obstetrician/gynecologists and general surgeons |
| Q38848447 | Laboratory Assays in Evaluation of Lynch Syndrome in Patients with Endometrial Carcinoma |
| Q38710498 | Loss of Mismatch Repair Protein Expression in Unselected Endometrial Adenocarcinoma Precursor Lesions |
| Q36879467 | Lynch syndrome in women less than 50 years of age with endometrial cancer |
| Q36758454 | Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium |
| Q47795729 | Lynch syndrome--related endometrial carcinomas show a high frequency of nonendometrioid types and of high FIGO grade endometrioid types |
| Q26777583 | Medical treatment for heavy menstrual bleeding |
| Q36958508 | Metastatic colorectal carcinoma mimicking primary ovarian carcinoma presenting as 'giant' ovarian tumors in an individual with probable Lynch syndrome: a case report |
| Q92628365 | Microsatellite instability in endometrial cancer: New purpose for an old test |
| Q38741029 | Mismatch repair deficiency testing in clinical practice |
| Q58630051 | Missed opportunities: Genetic counseling and testing among an ethnically diverse cohort of women with endometrial cancer |
| Q39360426 | Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper |
| Q47314904 | Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer |
| Q39897235 | Obstetrics/gynecology residents' knowledge of hereditary breast and ovarian cancer and Lynch syndrome |
| Q47397560 | One size may not fit all: the debate of universal tumor testing for Lynch syndrome |
| Q92151317 | PMS2 germline mutation c.1577delA (p.Asp526Alafs*69)-induced Lynch syndrome-associated endometrial cancer: A case report |
| Q60167348 | Pathologic features of endometrial carcinoma associated with HNPCC |
| Q51023349 | Performance characteristics of a brief Family History Questionnaire to screen for Lynch syndrome in women with newly diagnosed endometrial cancer. |
| Q51065192 | Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing. |
| Q43625600 | Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry |
| Q28080146 | Practical issues related to uterine pathology: staging, frozen section, artifacts, and Lynch syndrome |
| Q47745633 | Prevalence and prognostic role of mismatch repair gene defect in endometrial cancer patients |
| Q37288374 | Prevalence of Lynch syndrome among patients with newly diagnosed endometrial cancers |
| Q81524412 | Prophylactic surgery prevents endometrial and ovarian cancer in Lynch syndrome |
| Q34459728 | Prospective study of combined colon and endometrial cancer screening in women with lynch syndrome: a patient-centered approach |
| Q38203354 | Recent and current Phase II clinical trials in endometrial cancer: review of the state of art. |
| Q36642662 | Relationship of lower uterine segment cancer with Lynch syndrome: a novel case with an hMLH1 germline mutation |
| Q90011732 | Review of immunohistochemical typing of endometrial carcinoma at the Lagos University Teaching Hospital |
| Q34163849 | Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma |
| Q35179515 | Risk-reducing surgery in hereditary gynecological cancer: Clinical applications in Lynch syndrome and hereditary breast and ovarian cancer |
| Q49993894 | Second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae |
| Q50720259 | Targeted Screening With Combined Age- and Morphology-Based Criteria Enriches Detection of Lynch Syndrome in Endometrial Cancer. |
| Q24562824 | Testing women with endometrial cancer for lynch syndrome: should we test all? |
| Q36920374 | Testing women with endometrial cancer to detect Lynch syndrome |
| Q63966105 | The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome |
| Q34081267 | The genetic basis of Lynch syndrome and its implications for clinical practice and risk management |
| Q38789406 | The genetic prediction of risk for gynecologic cancers. |
| Q40733621 | The gynecological surveillance of women with Lynch syndrome in Sweden |
| Q90953408 | The practice of universal screening for Lynch syndrome in newly diagnosed endometrial carcinoma |
| Q92000687 | The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis |
| Q34380045 | The revised Bethesda guidelines: extent of utilization in a university hospital medical center with a cancer genetics program |
| Q53585426 | The role of hereditary nonpolyposis colorectal cancer in the management of familial ovarian cancer. |
| Q88801413 | Towards value-based universal Lynch syndrome identification in endometrial cancer patients |
| Q36990271 | Triple synchronous primary malignancies of the colon, endometrium and kidney in a patient with Lynch syndrome treated via minimally invasive techniques |
| Q98293212 | Understanding inherited risk in unselected newly diagnosed patients with endometrial cancer |
| Q104739131 | Universal screening for Lynch syndrome in uterine cancer patients: A quality improvement initiative |
| Q88575143 | Uterine endometrial carcinoma with DNA mismatch repair deficiency: magnetic resonance imaging findings and clinical features |
| Q37492615 | Utility of MLH1 methylation analysis in the clinical evaluation of Lynch Syndrome in women with endometrial cancer |
| Q83443434 | [Hierarchy for diagnostic and etiological management in menometrorrhagia] |
Search more.